{"nctId":"NCT00972777","briefTitle":"Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis","startDateStruct":{"date":"2009-10"},"conditions":["Bacterial Conjunctivitis"],"count":474,"armGroups":[{"label":"Besifloxacin","type":"EXPERIMENTAL","interventionNames":["Drug: Besifloxacin"]},{"label":"Vehicle","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Vehicle (Placebo)"]}],"interventions":[{"name":"Besifloxacin","otherNames":["Besivance"]},{"name":"Vehicle (Placebo)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects who are at least one year of age.\n* Subjects who have a clinical diagnosis of acute bacterial conjunctivitis.\n* Subjects who are willing to discontinue contact lens wear for the duration of the study.\n\nExclusion Criteria:\n\n* Subjects who have any uncontrolled systemic disease or debilitating disease.\n* Subjects with known sensitivity or contraindications to besifloxacin, fluoroquinolones or any ingredients in study drugs.\n* Subjects who are expected to require treatment with any disallowed medications.","healthyVolunteers":false,"sex":"ALL","minimumAge":"1 Year","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Clinical Resolution","description":"The absence of both conjunctival discharge and bulbar conjunctival injection.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"89","spread":null},{"groupId":"OG001","value":"62","spread":null}]}]}]},{"type":"PRIMARY","title":"Microbial Eradication","description":"The absence of ocular bacteria that were present at or above pathogenic threshold levels at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"115","spread":null},{"groupId":"OG001","value":"77","spread":null}]}]}]},{"type":"SECONDARY","title":"Clinical Resolution","description":"The absence of both conjunctival discharge and bulbar conjunctival injection.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"103","spread":null},{"groupId":"OG001","value":"94","spread":null}]}]}]},{"type":"SECONDARY","title":"Microbial Eradication","description":"The absence of ocular bacteria that were present at or above pathogenic threshold levels at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"115","spread":null},{"groupId":"OG001","value":"91","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":228},"commonTop":[]}}}